EEG biomarkers in Alzheimer's and prodromal Alzheimer's: a comprehensive analysis of spectral and connectivity features

Chowtapalle Anuraag Chetty,Harsha Bhardwaj,G. Pradeep Kumar,T. Devanand,C. S. Aswin Sekhar,Tuba Aktürk,Ilayda Kiyi,Görsev Yener,Bahar Güntekin,Justin Joseph,Chinnakkaruppan Adaikkan
DOI: https://doi.org/10.1186/s13195-024-01582-w
2024-10-25
Alzheimer s Research & Therapy
Abstract:Biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI, or prodromal AD) are highly significant for early diagnosis, clinical trials and treatment outcome evaluations. Electroencephalography (EEG), being noninvasive and easily accessible, has recently been the center of focus. However, a comprehensive understanding of EEG in dementia is still needed. A primary objective of this study is to investigate which of the many EEG characteristics could effectively differentiate between individuals with AD or prodromal AD and healthy individuals.
neurosciences,clinical neurology
What problem does this paper attempt to address?